Abingdon Health Plc (AIM:ABDX)
10.00
+0.15 (1.52%)
Jul 28, 2026, 8:07 AM GMT
Abingdon Health Income Statement
Financials in millions GBP. Fiscal year is July - June.
Millions GBP. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
| 9.57 | 8.43 | 6.14 | 4.05 | 2.84 | 11.62 | |
Revenue Growth | 13.56% | 37.39% | 51.67% | 42.68% | -75.60% | 121.93% |
Cost of Revenue | 5.61 | 4.69 | 2.46 | 1.97 | 6.43 | 7.48 |
Gross Profit | 3.96 | 3.74 | 3.68 | 2.08 | -3.59 | 4.14 |
Selling, General & Admin | 7.88 | 7.71 | 5.31 | 5.22 | 6.65 | 7.55 |
Other Operating Expenses | -1.81 | -1.67 | -0.5 | 0.44 | 11.29 | 3.32 |
Total Operating Expenses | 6.07 | 6.05 | 4.81 | 5.66 | 17.94 | 10.86 |
Operating Income | -3.15 | -3.51 | -1.37 | -3.59 | -21.53 | -6.72 |
Interest Income | 0.07 | 0.1 | 0.03 | 0.09 | 0 | - |
Interest Expense | -0.08 | -0.09 | -0.06 | -0.08 | -0.07 | -0.23 |
Total Non-Operating Income (Expense) | -0.01 | 0.01 | -0.03 | 0.01 | -0.07 | -0.23 |
Pretax Income | -3.16 | -3.5 | -1.4 | -3.57 | -21.59 | -6.95 |
Provision for Income Taxes | 0.08 | -0.08 | -0.13 | -0.11 | -0.33 | 0.02 |
Net Income | -3.24 | -3.42 | -1.27 | -3.47 | -21.26 | -6.97 |
Net Income to Common | -3.24 | -3.42 | -1.27 | -3.47 | -21.26 | -6.97 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 387 | 367 | 305 | 304 | 292 | 263 |
Shares Outstanding (Diluted) | 387 | 367 | 305 | 306 | 292 | 263 |
Shares Change | 5.50% | 20.32% | -0.36% | 4.87% | 10.91% | 5.03% |
EPS (Basic) | -0.01 | -0.01 | -0.00 | -0.01 | -0.07 | -0.03 |
EPS (Diluted) | -0.01 | -0.01 | -0.00 | -0.01 | -0.07 | -0.03 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Free Cash Flow | -2.62 | -3.51 | -1.69 | 0.84 | -8.42 | -19.64 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Per Share | -0.01 | -0.01 | -0.01 | 0.00 | -0.03 | -0.07 |
Gross Margin | 41.38% | 44.32% | 59.97% | 51.30% | -126.70% | 35.66% |
Operating Margin | -32.92% | -41.63% | -22.38% | -88.70% | -759.37% | -57.84% |
Profit Margin | -33.88% | -40.51% | -20.72% | -85.76% | -749.98% | -60.02% |
FCF Margin | -27.36% | -41.63% | -27.61% | 20.72% | -297.04% | -169.02% |
EBITDA | -2.47 | -2.91 | -0.95 | -2.81 | -12.7 | -5.97 |
EBITDA Margin | -25.75% | -34.54% | -15.44% | -69.57% | -447.94% | -51.39% |
EBIT | -3.15 | -3.51 | -1.37 | -3.59 | -21.53 | -6.72 |
EBIT Margin | -32.92% | -41.63% | -22.38% | -88.70% | -759.37% | -57.84% |
Effective Tax Rate | -2.59% | 2.32% | 9.15% | 2.94% | 1.53% | -0.27% |